 |
|
nimotuzumab
A humanized monoclonal antibody directed against the epidermal growth factor receptor (EGFR) with potential antineoplastic activity. Nimotuzumab binds to and inhibits EGFR, resulting in growth inhibition of tumor cells that overexpress EGFR. This agent may act synergistically with radiation therapy. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| Synonyms: | | TheraCim hR3
Thera-CIM-hr3 | | | | Foreign brand name: | | Theraloc | | |
|
|
